专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

EP2435572A4 ANTIGENIC CHIMERIC TICK-BORNE ENCEPHALITIS VIRUS/DENGUE VIRUS TYPE 4 RECOMBINANT VIRUSES 有权
标题翻译：和重组病毒抗原嵌合蜱传脑炎病毒登革热病毒4型
公开(公告)号：EP2435572A4
公开(公告)日：2013-07-10
申请号：EP10781321
申请日：2010-05-28
申请人： US HEALTH
发明人： PLETNEV ALEXANDER G , MURPHY BRIAN R , ENGEL AMBER R
IPC分类号： C12N15/40 , A61K39/12 , A61K39/295 , C07K14/18 , C12N7/00 , C12N7/01
CPC分类号： C12N7/00 , A61K39/12 , A61K2039/5254 , A61K2039/5256 , A61K2039/70 , C12N2770/24134 , C12N2770/24151
摘要： Disclosed herein are chimeric TBEV/DEN4 flaviviruses including a first nucleic acid molecule including a 5' non-coding region (NCR) from a DEN4 virus, a nucleic acid encoding a C protein and non-structural proteins from a DEN4 virus, and a 3' NCR from a DEN4 virus, wherein nonstructural protein NS4B includes a phenylalanine at amino acid position 112, nonstructural protein NS5 includes an alanine at amino acid position 654 and an alanine at amino acid position 655, and the 3' NCR includes a deletion of nucleotides 10478-10507. The chimeric construct also includes a second nucleic acid molecule, which is operably linked to the first nucleic acid molecule, encoding a prM protein and an E protein from a TBEV, wherein the E protein includes an amino acid substitution that differs from the wild type TBEV at amino acid position 315 and a tryptophan at amino acid position 240. Also disclosed are methods of eliciting an immune response using the disclosed TBEV/DEN4 chimeric flaviviruses and immunogenic compositions including the disclosed chimeric flaviviruses and a pharmaceutically acceptable carrier.
摘要翻译：公开于是嵌合TBEV / DEN4黄病毒，其包括第一核酸分子包含5“非编码区（NCR）从DEN4病毒，核酸编码来自DEN4病毒C蛋白和非结构蛋白，和一个3 “NCR从DEN4病毒，worin非结构蛋白NS4B包括在氨基酸位置112处的苯丙氨酸，非结构蛋白NS5包括在氨基酸位置654和在氨基酸位置655的丙氨酸丙氨酸，和3” NCR包括缺失的核苷酸的 10478-10507。因此，嵌合构建体包含第二核酸分子，所有这一切都被可操作地连接至第一核酸分子，编码prM蛋白和在从TBEV E蛋白，worin E蛋白包括野生型氨基酸置换从TBEV确实而异在氨基酸位置315和在氨基酸位置240色氨酸所以盘是游离缺失引起对使用游离缺失TBEV / DEN4嵌合黄病毒和免疫原性组合物，包括在盘游离缺失的嵌合黄病毒和药学上可接受的载体中的盘的免疫应答的方法。

2. 发明公开

EP1572947A4 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS 有权转让
标题翻译：获得重组人流感病毒2型PARA（HPIV2）的cDNA和在免疫原性组合物重组HPIV2的用途，和作为矢量引发针对PIV和其他人类病原体免疫反应的
公开(公告)号：EP1572947A4
公开(公告)日：2008-09-03
申请号：EP03752537
申请日：2003-09-18
申请人： US HEALTH
发明人： SKIADOPOULOS MARIO H , MURPHY BRIAN R , COLLINS PETER L
IPC分类号： A61K39/00 , A61K39/155 , C07K14/115 , C07K14/135 , C12N7/04 , C12N7/00 , A01N63/00 , C12N7/01 , C12Q1/70
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/155 , A61K2039/5254 , A61K2039/5256 , C12N7/00 , C12N2760/18334 , C12N2760/18634 , C12N2760/18643 , C12N2760/18722 , C12N2760/18734 , C12N2760/18743 , C12N2760/18762
摘要： Recombinant human parainfluenza virus type 2 (HPIV2) viruses and related immunogenic compositions and methods are provided. The recombinant HPIV2 viruses, including HPIV2 chimeric and chimeric vector viruses, provided according to the invention are infectious and attenuated in permissive mammalian subjects, including humans, and are useful in immunogenic compositions for eliciting an immune responses against one or more PIVs, against one or more non-PIV pathogens, or against a PIV and a non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a recombinant HPIV2 genome or antigenome.

3. 发明公开

EP1456398A4 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 1 (HPIVI) FROM CDNA 有权
标题翻译：提取从cDNA重组人副流感病毒1型（HPIVI）JOURNAL
公开(公告)号：EP1456398A4
公开(公告)日：2006-09-27
申请号：EP02799195
申请日：2002-11-21
申请人： US HEALTH
发明人： MURPHY BRIAN R , COLLINS PETER L , SKIADOPOULOS MARIO H , NEWMAN JASON T
IPC分类号： A61K20060101 , A61K35/76 , A61K39/155 , A61P31/14 , C07K14/115 , C12N7/00 , C12N7/01 , C12N7/04 , C12N15/45 , C12N15/86 , C12P21/04
CPC分类号： C07K14/005 , A61K2039/525 , C12N7/00 , C12N15/86 , C12N2760/18622 , C12N2760/18643 , C12N2760/18661
摘要： Recombinant human parainfluenza virus type I (HPIVI) compositions, formulations, and methods are provided. The recombinant HPIVI viruses and HPIVI chimeric and chimeric vector viruses provided according to the invention are infectious and attenuated in permissive mammalian subjects, including humans, are useful in immunogenic composition s for eliciting an immune responses against one or more PIVs, against one or more non-PIV pathogens, or against a PIV and a non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a recombinant HPIVI genome or anti genome.

4. 发明公开

EP1402075A4 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES 有权
标题翻译：登革热病毒的衰减合适的突变和嵌合登革病毒发展
公开(公告)号：EP1402075A4
公开(公告)日：2005-05-11
申请号：EP02739358
申请日：2002-05-22
申请人： US HEALTH
发明人： WHITEHEAD STEPHEN S , MURPHY BRIAN R , HANLEY KATHRYN A , BLANEY JOSEPH E JR
IPC分类号： A61K39/12 , A61K39/193 , A61K39/295 , C07H21/04 , C07K1/00 , C07K14/00 , C07K17/00 , C12N7/00 , C12N7/01 , C12N7/04 , C12Q1/68 , C12Q1/70 , A61K39/42 , C07H21/02 , C12P19/34 , G01N33/48 , G01N33/53
CPC分类号： A61K39/12 , A61K39/295 , A61K2039/5252 , A61K2039/5254 , A61K2039/5256 , A61K2039/54 , A61K2039/575 , A61K2039/70 , C12N7/00 , C12N2770/24121 , C12N2770/24134 , C12N2770/24161 , C12N2770/24162 , C12N2770/24171 , C12Q1/701 , C12Q2600/156 , G01N2333/18 , G01N2500/10
摘要： A menu of mutations was developed that is useful in fine-tuning the attenuation and growth characteristics of dengue virus vaccines.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式